Interview: Nkaki Matlala – Vice-Chairman of the Public Health Enhancement…
The Vice-Chairman of the Public Health Enhancement Fund talks about how the shortage of medical doctors and the fight against TB, HIV and AIDS in South Africa led the health…
Working together to enhance health. No single sector in South Africa, whether public or private, can successfully confront the immense challenge of the quadruple burden of disease. It requires combined forces, shared vision and commitment to working together. The Minister of Health officially launched the Social Compact Forum on 8 November 2012. The launch of the Forum was applauded by government and the ANC, as an initiative that leads the way for cooperation between the public and private sectors.
Establishing a social compact in healthcare. To achieve this noble vision the Minister and participating private sector companies established a Social Compact Forum and the Public Health Enhancement Fund (PHEF). The Social Compact Forum which will interact with the Minister and the Public Health Enhancement Fund (PHEF) is a financing instrument established by the Social Compact.
The Public Health Enhancement Fund (PHEF) will be managed by the private sector through the establishment of a not for profit entity in accordance with the Companies Act. Collection and disbursement of funds will be for the benefit of transformative healthcare projects, to be jointly agreed to between the Minister and the private sector. Payments from the fund will be made directly to vendors or, in the case of projects, to the providers of services to the beneficiaries of the projects, as determined by the Board of the PHEF from time to time. The rationale for the fund is for private sectors to contribute in strengthening the health sector and to build trust between the public and private sector. The initiative also aims to leverage the funds within the private sector to maximise benefits for the types of projects envisaged, rather than adopting an individual or silo approach which results in a number of fragmented, smaller projects which do not necessarily have the impact that is required. Ultimately, it is envisaged that this institutionalised engagement will assist in shaping a better future healthcare system for all, regardless of whether they be from the private or public health sector. The funding formula has been developed by corporate lawyers, auditors and BBBEE consultants to ensure that the contributions into the fund are recognised under the Socio-Economic Development (SED) element of the BBBEE balanced scorecard. Empowerdex has confirmed this. The BBBEE Act and its balanced scorecard require companies to spend 1% of Net Profit after tax (NPAT) for maximal SED recognition. The funding formula for the PHEF requires 0,75% for participation in the Fund. This means that participants would contribute 75% of their required SED obligation into the fund. Participation in the initiative comes at no additional cost or earnings dilution, unless companies decide to exceed the 1% NPAT scorecard requirement. Contributing companies stand to benefit from an institutionalised engagement with government, through less fragmentation of SED activities and more efficient channelling of resources.
Contact:
Tel: 011 239 6734
Fax: 011 239 6018
Address:
Building 8, Healthcare Park,
Woodlands Drive, Woodmead, 2191
Web: www.phef.co.za
The Vice-Chairman of the Public Health Enhancement Fund talks about how the shortage of medical doctors and the fight against TB, HIV and AIDS in South Africa led the health…
African healthcare and pharma are moving from ambition to action. Regular PharmaBoardroom contributor Lenias Hwenda explains how, after years of over-dependence on global supply chains, fragmented regulation, and limited local…
Africa accounts for 19 percent of the world’s population and one-quarter of the global disease burden. However, for a host of reasons – both real and perceptual – the continent…
Writing in the July 2025 edition of DIA’s Global Forum magazine, Alex Juma Ismail of the African Union Development Agency – New Partnership for Africa’s Development (AUDA-NEPAD) and Vicki Gold,…
Building on the recent controversy over Tanzania’s handling of a suspected Marburg virus outbreak, Medicines for Africa’s Lenias Hwenda explores how African nations often face disproportionate consequences for outbreak transparency—penalties…
John M. Mwangi of Bayer Pharmaceuticals, writing in the December 2024 edition of DIA’s Global Forum magazine, examines why longstanding calls to implant more of the pharmaceutical manufacturing chain into…
The IFPMA’s Sarah Adam, writing in the July 2024 edition of DIA’s Global Forum magazine, looks back on an insightful discussion on the progress towards an African Medicines Agency at…
Several major scientific breakthroughs in HIV prevention and treatment in the past 40 years have successfully transformed HIV from a near-certain ‘death sentence’ to a manageable chronic disease where many…
In 2024, people living with HIV have more, and more varied, access to HIV prevention and treatment options than ever before. Thanks to global activism efforts forcing pharma to step…
A leading voice in the global fight against HIV, Professor Linda-Gail Bekker works across both scientific research and activism. As CEO and founder of the Desmond Tutu Health Foundation, Prof…
Medicines for Africa’s Lenias Hwenda reflects on Moderna’s recent decision not to go ahead with plans for a vaccine manufacturing facility in Kenya, and why local production remains crucial to…
Medicines for Africa’s Lenias Hwenda argues that the success of the much-talked-about African Medicines Agency hinges on a critical mass of African national regulators achieving WHO Level 3 maturity status.…
Writing in the February 2024 edition of the DIA Global Forum magazine, Verena Pfaffinger and Ilona Baraniak-Lang of PharmaLex examine how the drug shortages seen in the global south during…
See our Cookie Privacy Policy Here